🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Worlds cannot express how proud I am! Ana I. Velázquez Mañana, MD, MSc, FASCO achieving FASCO AND Healio disruptive innovators award for your work in heath equity and advocacy! Love watching all you BOTH accomplish!

Providing #patientcentric care closer to 🏠with your hospital at home work is EXACTLY the direction we need to be moving! Kudos Bobby Daly Love seeing ASCO quality work getting a spotlight #ASCO25! Memorial Sloan Kettering Cancer Center MSK Department of Medicine #lcsm

Thanks to Eric J. Small, MD, FASCO Cardinale B. Smith Erika Hamilton, MD and countless others who worked tirelessly to orchestrate this event! #ASCO25 has transcended all expectations and it’s only day3! Thank you for inspiring, educating and putting patients first!

This is the kind of waterfall plot you want to see! excited about this option for our patients who harbor EGFR exon 20 insertions. With not as many tx options in this space , I am thrilled we have an oral therapy option to talk about! #lcsm #SoMe Helena Yu

Thank you Jarushka Naidoo for this summary! Love seeing my OG mentor Benjamin Levy sharing data on frontline Dato-DXD . 🩺Lessons learned from clinic: 👄the stomatitis is significant, esp if not pre-treated w/ dex rinse , diligent oral hygiene , avoiding irritants +more #LCSM

Loved seeing Dr Wozniak , Dr Nagashree Seetharamu & Courtney Lung Cancer Research Foundation booth 📍front & center when you 🚶‍♀️in exhibit hall! Get your : -🫁tear away pads - patient ed materials on trials 101, biomarker testing 📚 -exchange ideas 💡 -join our #togetherseparately events #onctwitter

Thrilled to join this ⭐️ panel and hear about all #ASCO25 updates hot off the press! Thank you Oncology Brothers for including me! #CME

📣 Join us 6/20 Memorial Sloan Kettering Cancer Center for a CME on this ever evolving field! ✔️Mitigating toxicity is imperative! I am honored and humbled to join these trailblazers and soak in all the ways we can help our pts live better with improved QoL. #lcsm #SoMe #pfacq MSK Department of Medicine

Timely IASLC Lung Cancer Considered Podcast out now reviewing latest lung trials presented at #ASCO25 #lcsm

So proud of Alissa Cooper, MD teaching us all about #ADCs in #SCLC Memorial Sloan Kettering Cancer Center #oncologytoxicitysymposium highlighting Bobby Daly Hospital at home trial looking at safety of delivering tarlatamab in the out pt setting. Stay tuned for more! #LCSM MSK CME

What fun way to spend a Saturday morning learning with Oncology Brothers and these incredible thoracic oncologists! Thank you for having us! #asco2025 updates! CM816 OS data Mariposa and cocoon IMforte DELLphi 301 tarlatamab So much more !

Great to have approvals in this space! 👄- The stomatits is challenging. Premedication is key, proactive rather than reactive. Dex mouth rinse, ice chips in chemo chair, oral hygiene! Low threshold to dose reduce.

📣HAPPENING TODAY! 3:30pEST Join Dr. Piotrowska , Dr. Mohindra and myself for a PRACTICE changing #ASCO25 update Lung Cancer Research Foundation FREE monthly #togetherseparately event! Updates on: ✅NEW Dato- dxd approval ☑️small cell ✔️NSCLC #LCSM 🫁 screening ⬇️ lungcancerresearchfoundation.org/event/ts-2025-…

Reflecting about: “ What #asco2025 meant to me” and this video of these incredible folks doing their BEST #wellnesswalkoff just about sums it up! Advocates, patients & caregivers coming together to share ONE WORD summary of ASCO. #SoMe #lcsm #PRO #MedEd Who’s joining next yr?

Understudied Challenges in Young Lung Cancer: from sexual health, financial wellbeing, and psycho-social needs. More in our recently published paper: frontiersin.org/journals/oncol…

#ASCO25 recap on topic we address daily from these INCREDIBLE folks! ✔️RINV & olanzapine ✔️Nplate , can we extrapolate this data to other solid tumors?When is right ⏰to start? data is sparse ✔️length of steroids &pneumonitis, what about RT pneumonitis? TKI pneumonitis?

➡️ Treatment of HER2-mutant #NSCLC is a rapidly evolving and complex space Dr Isabel Preeshagul and Dr Eric K. Singhi, MD join the Oncology Brothers to discuss approaches to different Tx scenarios in HER2-mut NSCLC Get the highlights of the conversation in this post video 📹 See the full

Treatment Algorithm: This is the algorithm we have used during our discussion w/ Deepa Rangachari, MD, FASCO for Stage I-III non-small cell #LungCancer #OncTwitter #MedTwitter #lcsm

Congrats to the authors & Dr Joseph McCollom DO on your 1st ,1st author paper! 💊tip #3- long term challenges with toxicity impact emotional, sexual and physical health. Survivorship is difficult to navigate for many reasons ! Thank you for highlighting some⬇️